Mechanisms of antimicrobial peptide action and resistance

Pharmacological Reviews

Volumn 55, Issue 1, 2003, Pages 27-55

  Yeaman, Michael R ^a   Yount, Nannette Y ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PEPTIDE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BIOSYNTHESIS; CELL DEATH; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; HYDROPHOBICITY; IMMUNITY; INFECTION RESISTANCE; MEMBRANE BINDING; MEMBRANE COMPONENT; MEMBRANE POTENTIAL; MOLECULAR MODEL; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, MICROBIAL; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037371597     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.55.1.2     Document Type: Review

References (157)

1. Andrade AC, Van Nistelrooy JG, Peery RB, Skatrud PL, and De Waard MA (2000) The role of ABC transporters from Aspergillus nidulans in protection against cytotoxic agents and in antibiotic production. Mol Gen Genet 263:966-977.
2. Angel CS, Ruzek M, and Hostetter MK (1994) Degradation of C3 by Streptococcus pneumoniae. J Infect Dis 170:600-608.
3. Banemann A, Deppisch H, and Gross R (1998) The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect Immun 66:5607-5612.
4. Bayer AS, Cheng D, Yeaman MR, Corey GR, McClelland RS, Harrel LJ, and Fowler VG (1998) In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother 42:3169-3172.
5. Bayer AS, Prasad R, Chandra J, Koul A, Smriti M, Varma A, Skurray RA, Firth N, Brown MH, Koo SP, and Yeaman MR (2000) In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect Immun 68:3548-3553.
6. Belden WJ and Miller SI (1994) Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci. Infect Immun 62:5095-5101.
7. Bechinger B, Zasloff M, and Opella SJ (1993) Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci 2:2077-2084.
8. Bello J, Bello HR, and Granados E (1982) Conformation and aggregation of melittin: dependence on pH and concentration. Biochemistry 21:461-465.
9. Bengoechea JA and Skurnik M (2000) Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol Microbiol 37:67-80.
10. Bessalle R, Haas H, Goria A, Shalit I, and Fridkin M (1992) Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Antimicrob Agents Chemother 36:313-317.
11. Bessalle R, Kapitkovsky A, Gorea A, Shalit I, and Fridkin M (1990) All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 274:151-155.
12. Beven L, Helluin O, Molle G, Duclohier H, and Wroblewski H (1999) Correlation between anti-bacterial activity and pore sizes of two classes of voltage-dependent channel-forming peptides. Biochim Biophys Acta 1421:53-63.
13. Blondelle SE and Houghten RA (1992) Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry 31:12688-12694.
14. Blondelle SE, Lohner K, and Aguilar M (1999) Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. Biochim Biophys Acta 1462:89-108.
15. Boman HG, Agerberth B and Boman (1993) A Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61:2978-2984.
16. Breukink E and de Kruijff B (1999) The lantibiotic nisin, a special case or not? Biochim Biophys Acta 1462:223-234.
17. Brodsky IE, Ernst RK, Miller SI, and Falkow S (2002) mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides. J Bacteriol 184:3203-3213.
18. Brotz H, Bierbaum G, Leopold K, Reynolds PE, and Sahl HG (1998) The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother 42:154-160.
19. Cabiaux V, Agerberth B, Johansson J, Homble F, Goormaghtigh E, and Ruysschaert JM (1994) Secondary structure and membrane interaction of PR-39, a Pro+Argrich antibacterial peptide. Eur J Biochem 224:1019-1027.
20. th Genreal Meeting for the American Society for Microbiology, May 17-21 Atlanta GA
21. Chitnis SN and Prasad KS (1990) Seminalplasmin, an antimicrobial protein from bovine seminal plasma, inhibits peptidoglycan synthesis in Escherichia coli. FEMS Microbiol Lett 60:281-284.
22. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, and Strieter RM (2001) Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 167:623-627.
23. Dathe M and Wieprecht T (1999) Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta 1462:71-87.
24. Dathe M, Nikolenko H, Meyer J, Beyermann M, and Bienert M (2001) Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett 501:146-150.
25. Dathe M, Schumann M, Wieprecht T, Winkler A, Beyermann M, Krause E, Matsuzaki K, Murase O and Bienert M (1996) Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 35:12612-12622.
26. Dathe M, Wieprecht T, Nikolenko H, Handel L, Maloy WL, MacDonald DL, Beyermann M, and Bienert M (1997) Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett 403:208-212.
27. del Castillo FJ, del Castillo I, and Moreno F (2001) Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase. J Bacteriol 183:2137-2140.
28. Dhawan VK, Yeaman MR, Cheung AL, Kim E, Sullam PM, and Bayer AS (1997) Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun 65:3293-3299.
29. Dhawan VK, Bayer AS, and Yeaman MR (2000) Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 44:3206-3209.
30. Dimarcq JL, Bulet P, Hetru C, and Hoffmann J (1998) Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers 47:465-477.
31. Dorrer E and Teuber M (1977) Induction of polymyxin resistance in Pseudomonas fluoreseens by phosphate limitation. Arch Microbiol 114:87-89.
32. Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM, and Raj PA (1998) Candidacidal activity of salivary histatins: identification of a histatin 5-binding protein on Candida albicans. J Biol Chem 273:20438-20447.
33. Ehrenstein G and Lecar H (1977) Electrically-gated ionic channels in lipid bilayers. Q Rev Biophys 10:1-34.
34. Eisenberg D (1984) Three-dimensional structure of membrane and surface proteins. Annu Rev Biochem 53:595-623.
35. Emerson RW (1841) In, Compensation, from Essays - First Series. Library of America, NY
36. Epand RM and Vogel HJ (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462:11-28.
37. Ernst RK, Guina T, and Miller SI (1999) How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J Infect Dis 179:S326-330.
38. Ernst RK, Yi EC, Guo L, Lim KB, Burns JL, Hackett M, and Miller SI (1999) Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Sci. ence (Wash DC) 286:1561-1565.
39. Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, and Hoffmann JA (1996) Structure-activity analysis of thanatin, a residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci USA 93:1221-1225.
40. Fields PI, Groisman EA, and Heffron F (1989) A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science (Wash DC) 243:1059-1062.
41. Florin-Christensen J, Suarez CE, Florin-Christensen M, Wainszelbaum M, Brown WC, McElwain TF, and Palmer GH (2001) A unique phospholipid organization in bovine erythrocyte membranes. Proc Natl Acad Sci USA 98:7736-7741.
42. Friedrich C, Scott MG, Karunaratne N, Yan H, and Hancock RE (1999) Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob Agents Chemother 43:1542-1548.
43. Ganz T (2001) Fatal attraction evaded - how pathogenic bacteria resist cationic polypeptides. J Exp Med 193:F31-F34.
44. 2 environments. J Bacteriol 179:7040-7045.
45. Groisman EA (2001) The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol 183:1835-1842.
46. Guina T, Yi EC, Wang H, Hackett M, and Miller SI (2000) A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol 182:4077-4086.
47. Gunn JS and Miller SI (1996) PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 178:6857-6864.
48. Gunn JS, Lim KB, Krueger J, Kim K, Guo L, Hackett M, and Miller SI (1998) PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 27:1171-1182.
49. Guo L, Lim KB, Poduje CM, Daniel M, Gunn JS, Hackett M, and Miller SI (1998) Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189-198.
50. Gyurko C, Lendenmann U, Troxler RF, and Oppenheim FG (2000) Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Antimicrob Agents Chemother 44:348-354.
51. Hancock RE (1997) Peptide antibiotics. Lancet 349:418-422.
52. Hancock RE and Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43:1317-1323.
53. Hara T, Kodama H, Kondo M, Wakamatsu K, Takeda A, Tachi T, and Matsuzaki K (2001) Effects of peptide dimerization on pore formation: Antiparallel disulfidedimerized magainin 2 analogue. Biopolymers 58:437-446.
54. Hara T, Mitani Y, Tanaka K, Uematsu N, Takakura A, Tachi T, Kodama H, Kondo M, Mori H, Otaka A, Nobutaka F, and Matsuzaki K (2001) Heterodimer formation between the antimicrobial peptides magainin 2 and PGLa in lipid bilayers: a cross-linking study. Biochemistry 40:12395-12399.
55. Helander IM, Kilpelainen I, and Vaara M (1994) Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study. Mol Microbiol 11:481-487.
56. Helander IM, Nummila K, Kilpelainen I, and Vaara M (1995) Increased substitution of phosphate groups in lipopolysaccharides and lipid A of polymyxin-resistant mutants of Salmonella typhimurium and Escherichia coli. Prog Clin Biol Res. 392:15-23.
57. Helmerhorst EJ, Breeuwer P, van't Hof W, Walgreen-Weterings E, Oomen LC, Veerman EC, Amerongen AV and Abee T (1999) The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem 274:7286-7291.
58. Hirakura Y, Koabyashi S, and Matsuzaki K (2002) Specific interactions of the antimicrobial peptide cyclic β-sheet tachyplesin I with lipopolysaccharides. Biochim Biophys Acta 1562:32-36.
59. Hirsh DJ, Hammer J, Maloy WL, Blazyk J, and Schaefer J (1996) Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers. Biochemistry 35:12733-12741.
60. Hong RW, Shchepetov M, Weiser JN, and Axelsen PH (2003) Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A. Antimicrob Agents Chemother 47:1-6.
61. Juretic D, Chen HC, Brown JH, Morell JL, Hendler RW, and Westerhoff HV (1989) Magainin 2 amide and analogues. Antimicrobial activity, membrane depolarization and susceptibility to proteolysis. FEBS Lett 249:219-223.
62. Kaduk C, Duclohier H, and Dathe M (1997) Influence of proline position upon the ion channel activity of alamethicin. Biophys J 72:2151-2159.
63. Kagan BL, Ganz T, and Lehrer RI (1994) Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology 87:131-149.
64. Kim DH, Lee DG, Kim KL, and Lee Y (2001) Internalization of tenecin 3 by a fungal cellular process is essential for its fungicidal effect on Candida albicans. Eur J Biochem 268:4449-4458.
65. Kobayashi S, Hirakura Y, and Matsuzaki K (2001) Bacteria-selective synergism between the antimicrobial peptides a-helical magainin 2 and cyclic β-sheet tachyplesin I: toward cocktail therapy. Biochemistry 40:14330-14335.
66. Kol MA, de Kroon AI, Rijkers DT, Killian JA, and de Kruijff B (2001) Membranespanning peptides induce phospholipid flop: a model for phospholipid translocation across the inner membrane of Escherichia coli. Biochemistry 40:10500-10506.
67. Kondejewski LH, Jelokhani-Niaraki M, Farmer SW, Lix B, Kay CM, Sykes BD, Hancock RE, and Hodges RS (1999) Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J Biol Chem 274:13181-13192.
68. Koo SP, Bayer AS, and Yeaman MR (2001) Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides. Infect Immun 69:4916-4922.
69. Koppelman CM, Den Blaauwen T, Duursma MC, Heeren RM, and Nanninga NJ (2001) Escherichia coli minicell membranes are enriched in cardiolipin. J. Bacteriol 183:6144-6147.
70. Kragol G, Lovas S, Varadi G, Condie BA, Hoffmann R, and Otvos L Jr (2001) The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochem 40:3016-3026.
71. Kupferwasser LI, Skurray RA, Brown MH, Firth N, Yeaman MR, and Bayer AS (1999) Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus. Antimicrob Agents Chemother 43:2395-2399.
72. Lasch P, Schultz CP, and Naumann D (1998) The influence of poly-(L-lysine) and porin on the domain structure of mixed vesicles composed of lipopolysaccharide and phospholipid: an infrared spectroscopic study. Biophys J 75:840-852.
73. Latal A, Degovics G, Epand RF, Epand RM, and Lohner K (1997) Structural aspects of the interaction of peptidyl-glycylleucine-carboxyamide, a highly potent antimicrobial peptide from frog skin, with lipids. Eur J Biochem 248:938-946.
74. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, and Selsted ME (1989) Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 84:553-561.
75. Lehrer RI and Ganz T (1996) Endogenous vertebrate antibiotics: defensins, protegrins and other cysteine-rich antimicrobial peptides. Ann NY Acad Sci 797:228-239.
76. Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, and Huang HW (1996) Membrane pores induced by magainin. Biochemistry 35:13723-13728.
77. Lysenko ES, Gould J, Bals R, Wilson JM, and Weiser JN (2000) Bacteria] phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect Immun 68:1664-1671.
78. Manniello JM, Heymann H, and Adair FW (1978) Resistance of spheroplasts and whole cells of Pseudomonas cepacia to polymyxin B. Antimicrob Agents Chemother 14:500-504.
79. Matsuzaki K (1998) Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta 1376:391-400.
80. Matsuzaki K (1999) Why and how are peptide-lipid interactions utilized for selfdefense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1462:1-10.
81. Matsuzaki K, Harada M, Funakoshi S, Fujii N, and Miyajima K (1991) Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim Biophys Acta 1063:162-170.
82. Matsuzaki K, Harada M, Handa T, Funakoshi S, Fujii N, Yajima H, and Miyajima K (1989) Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. Biochim Biophys Acta 981:130-134.
83. Matsuzaki K, Mitani Y, Akada KY, Murase O, Yoneyama S, Zasloff M, and Miyajima K (1998) Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry 37:15144-15153.
84. Matsuzaki K, Nakamura A, Murase O, Sugishita K, Fijii N, and Miyajima K (1997) Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry 36:2104-2111.
85. Matsuzaki K, Sugishita K, Harada M, Fujii N, and Miyajima K (1997) Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta 1327:119-130.
86. Mavri J and Vogel HJ (1996) Ion pair formation of phosphorylated amino acids and lysine and arginine side chains: a theoretical study Proteins 24:495-501.
87. McCoy AJ, Liu H, Falla TJ, and Gunn JS (2001) Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides. Antimicrob Agents Chemother 45:2030-2037.
88. McIntosh TJ, Lin H, Li S, and Huang C (2001) The effect of ethanol on the phase transition temperature and the phase structure of monounsaturated phosphatidylcholines. Biochim Biophys Acta 1510:219-230.
89. Mor A, Hani K, and Nicolas P (1994) The vertebrate pe)tide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J Biol Chem 269:31635-31641.
90. Nahaie MR, Goodfellow M, Minnikin DE, and Hajek V (1984) Polar lipid and isoprenoid quinone composition in the classification of Staphylococcus. J Gen Microbiol 130:2427-2437.
91. Oh J, Cajal Y, Dhurjati PS, Van Dyk TK, and Jain MK (2000) Cecropins induce the hyperosmotic stress response in Escherichia coli. Biochim Biophys Acta 1415:235-245.
92. Ohl ME and Miller SI (2001) Salmonella: a model for bacterial pathogenesis. Annu Rev Med 52:259-274.
93. Ohta M, Ito H, Masuda K, Tanaka S, Arakawa Y, Wacharotayankun R, and Kato N (1992) Mechanisms of antibacterial action of tachyplesins and polyphemusins, a group of antimicrobial peptides isolated from horseshoe crab hemocytes. Antimicrob Agents Chemother 36:1460-1465.
94. Oishi O, Yamashita S, Nishimoto E, Lee S, Sugihara G, and Ohno M (1997) Conformations and orientations of aromatic amino acid residues of tachyplesin I in phospholipid membranes. Biochemistry 36:4352-4359.
95. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, and Shai Y (1999) Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J 341:501-513.
96. Osapay K, Tran D, Ladokhin AS, White SH, Henschen AH, and Selsted ME (2000) Formation and Characterization of a Single Trp-Trp Cross-link in Indolicidin That Confers Protease Stability without Altering Antimicrobial Activity. J. Biol. Chem 275:12017-12022.
97. Palmer M (2001) The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 39:1681-1689.
98. Park CB, Kim HS, and Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253-257.
99. Pathak N, Salas-Auvert R, Ruche G, Janna MH, McCarthy D, and Harrison RG (1995) Comparison of the effects of hydrophobicity, amphiphilicity and alphahelicity on the activities of antimicrobial peptides. Proteins 22:182-186.
100. Peschel A and V Collins. (2001) Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides 22:1651-1659.
101. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, and van Strijp JA (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193:1067-1076.
102. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, and Gotz F (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins and other antimicrobial peptides. J Biol Chem 274:8405-8410.
103. Peschel A, Vuong C, Otto M and Gotz F (2000) The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother 44:2845-2847.
104. Proctor RA and Peters G (1998) Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin Infect Dis 27:419-422.
105. Proctor RA, Balwit JM, and Vesga O (1994) Variant subpopulations of Staphylococcus aureus as a cause of persistent infections. Infect. Agents Dis. 3:302-312.
106. Robey M, O'Connell W, and Cianciotto NP (2001) Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection. Infect Immun 69:4276-4286.
107. Rozek A, Friedrich CL, and Hancock RE (2000) Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 39:15765-15774.
108. Sansom MS (1991) The biophysics of peptide models of ion channels. Prog Biophys Mol Biol 55:139-235.
109. Schibli DJ, Hwang PM, and Vogel HJ (1999) Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold. Biochemistry 38:16749-16755.
110. Shafer WM, Martin LE, and Spitznagel JK (1986) Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granulocytes. Infect Immun 53:651-655.
111. Shafer WM, Qu X, Waring AJ, and Lehrer RI (1998) Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci USA 95:1829-1833.
112. Shai Y and Oren Z (2001) From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22:1629-1641.
113. Shankaramma SC, Athanassiou Z, Zerbe O, Moehle K, Mouton C, Bernardi F, Vrijbloed JW, Obrecht D, and Robinson (2002) Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. Chembiochem 3:1126-1133.
114. Sharma S, Verma I, and Khuller GK (1999) Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37Ra. Arch Microbiol 171:338-342.
115. Sitaram N and Nagaraj R (1999) Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim Biophys Acta 1462:29-54.
116. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, and Goguen JD (1992) A surface protease and the invasive character of plague. Science (Wash DC) 258:1004-1007.
117. Stumpe S and Bakker EP (1997) Requirement of a large K+-uptake capacity and of extracytoplasmic protease activity for protamine resistance of Escherichia coli. Arch Microbiol 167:126-136.
118. Stumpe S, Schmid R, Stephens DL, Georgiou G, and Bakker EP (1998) Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J Bacteriol 180:4002-4006.
119. Sugimura K and Nishihara T (1988) Purification, characterization and primary structure of Escherichia coli protease VII with specificity for paired basic residues: identity of protease VII and OmpT. J. Bacteriol. 170:5625-5632.
120. Tam JP, Wu C, and Yang JL (2000) Membranolytic selectivity of cystine-stabilized cyclic protegrins. Eur J Biochem 267:3289-3300.
121. Tang YQ, Yeaman MR, and Selsted ME (2002) Antimicrobial peptides from human platelets. Infect Immun 70:6524-6533.
122. Teuber M and Bader J (1976) Action of polymyxin B on bacterial membranes. Binding capacities for polymyxin B of inner and outer membranes isolated from Salmonella typhimurium G3O. Arch Microbiol 109:51-58.
123. Tytler EM, Anantharamaiah GM, Walker DE, Mishra VK, Palgunachari MN, and Segrest JP (1995) Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry 34:4393-4401.
124. Uematsu N and Matsuzaki K (2000) Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study. Biophys J 79:2075-2083.
125. Ulvatne H, Haukland HH, Samuelsen O, Kramer M, and Vorland LH (2002) Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. J Antimicrob Chemother 50:461-467.
126. Unger T, Oren Z, and Shai Y (2001) The effect of cyclization of magainin 2 and melittin analogues on structure, function and model membrane interactions: implication to their mode of action. Biochemistry 40:6388-6397.
127. Vaz Gomes A, de Waal A, Berden JA, and Westerhoff HV (1993) Electric potentiation, cooperativity and synergism of magainin peptides in protein-free liposomes. Biochemistry 32:5365-5372.
128. Verkleij AJ and Post JA (2000) Membrane phospholipid asymmetry and signal transduction. J Membr Biol 178:1-10.
129. Vesga O, Groeschel MC, Otten MF, Brar DW, Vann JM, and Proctor RA (1996) Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis 173:739-742.
130. Viljanen P and M. Vaara. (1984) Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Antimicrob Agents Chemother 25:701-705.
131. Vunnam S, Juvvadi P, and Merrifield RB (1997) Synthesis and antibacterial action of cecropin and proline-arginine-rich peptides from pig intestine. J Pept Res 49:59-66.
132. Wade D, Boman A, Wahlin B, Drain CM, Andreu D, Boman HG, and Merrifield RB (1990) All-D amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci USA. 87:4761-4765.
133. Wang W, Smith DK, Moulding K, and Chen HM (1998) The dependence of membrane permeability by the antibacterial peptide cecropin B and its analogs, CB-1 and CB-3, on liposomes of different composition. J Biol Chem 273:27438-27448.
134. Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, Savio EO, Paulusma-Annema A, Pauwels EK, and Nibbering PH (2001) 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 42:788-794.
135. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, and Nibbering PH (2000) Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 27:292-301.
136. Westerhoff HV, Zasloff M, Rosner JL, Hendler RW, De Waal A, Vaz Gomes A, Jongsma PM, Riethorst A, and Juretic D (1995) Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes. Eur J Biochem 228:257-264.
137. Wieprecht T, Dathe M, Beyermann M, Krause E, Maloy WL, MacDonald DL, and Bienert M (1997) Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry 36:6124-6132.
138. Wieprecht T, Dathe M, Epand RM, Beyermann M, Krause E, Maloy WL, MacDonald DL, and Bienert M (1997) Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry 36:12869-12880.
139. Wieprecht T, Dathe M, Krause E, Beyermann M, Maloy WL, MacDonald DL, and Bienert M (1997) Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett 417:135-140.
140. Williams RW, Starman R, Taylor KM, Gable K, Beeler T, Zasloff M, and Covell D (1990) Raman spectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa. Biochemistry 29:4490-4496.
141. Wu T, Yeaman MR, and Bayer AS (1994) In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother 38:729-732.
142. Xiong YQ, Bayer AS, and Yeaman MR (2002) Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins. J Infect Dis 186:668-677.
143. Yan H and R. E. W. Hancock. (2001) Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother 45:1558-1560.
144. Yang L, Harroun TA, Weiss TM, Ding L, and Huang HW (2001) Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 81:1475-1485.
145. Yang L, Weiss TM, Lehrer RI, and Huang HW (2000) Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys J 79:2002-2009.
146. Yeaman MR (1997) The role of platelets in antimicrobial host defense. Clin Infect Dis 25:951-968.
147. Yeaman MR and Bayer AS (1999) Antimicrobial peptides from platelets. Drug Resist Updates 2:116-126.
148. Yeaman MR, Bayer AS, Koo SP, Foss W, and Sullam PM (1998) Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest 101:178-187.
149. Yeaman MR, Gank KD, Bayer AS, and Brass EP (2002) Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicrob Agents Chemother 46:3883-3891.
150. Yeaman MR, Soldan SS, Ghannoum MA, Edwards JE Jr, Filler SG, and Bayer AS (1994) Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect Immun 64:1379-1384.
151. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature (Lond) 415:389-395.
152. Zhang L, Benz R, and Hancock RE (1999) Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry 38:8102-8111.
153. Zhang L, Dhillon P, Yan H, Farmer S, and Hancock RE (2000) Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:3317-3321.
154. Zhang L, Rozek A, and Hancock RE (2001) Interaction of cationic antimicrobial peptides with model membranes. J Biol Chem 276:35714-35722.
155. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho J, et al. (2002) Contribution of human a-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science (Wash DC) 298:995-1000.
156. Zhou Z, Lin S, Cotter RJ, and Raetz CRH (1999) Lipid A modifications characteristic of salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. J Biol Chem 274:18503-18514.
157. Zhou Z, Ribeiro AA, Lin S, Cotter RJ, Miller SI, and Raetz CR (2001) Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose and phosphoethanolamine incorporation. J Biol Chem 276:43111-43121.